















| 카탈로그 번호 | HB058016 |
|---|---|
| 설명 |
Tisotumab (HB058016) is a research-grade recombinant antibody targeting CD142. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 종 반응성 | Human |
| 응용 분야 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 숙주 종 | Human |
| 클론성 | Monoclonal |
| 이소타입 | IgG1-kappa |
| 발현 시스템 | Mammalian cells |
| 테스트된 응용 분야 | WB, FCM |
| 타겟 | Tissue factor, CD142, F3, Thromboplastin, Coagulation factor III, TF |
| 내독소 수준 | < 10 EU/mg |
| 순도 | >95% purity as determined by SDS-PAGE. |
| 정제 | Protein A/G purified from cell culture supernatant. |
| 등록번호 | P13726 |
| 형태 | Liquid |
| 저장 완충액 | 0.01M PBS pH 7.4 데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요. |
| 안정성 및 저장 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 대체 이름 | HuMax-TF-ADC, TF-011-MMAE, HuMax-TF, 1418628-81-5 |
| 배경 | Tissue factor (CD142/F3) is a ~33 kDa protein. Initiates blood coagulation by forming a complex with circulating factor VII or VIIa. The [TF:VIIa] complex activates factors IX or X by specific limited proteolysis. TF plays a role in normal hemostasis by initiating the cell-surface assembly and propagation of the coagulation protease cascade. CD142 is the therapeutic target of tisotumab vedotin (Tivdak). |
| 참고사항 | For research use only. Not suitable for clinical or therapeutic use. |

SEC-HPLC detection for Research Grade Tisotumab.

Detects CD142/F3/TF in indirect ELISAs.

SDS-PAGE for Research Grade Tisotumab

Flow-cytometry using anti-human CD142 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human CD142 monoclonal antibody (Catalog: HB058016) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

Western blot analysis was performed using anti-CD142/F3/TF monoclonal antibody at 1μg/ml on various samples.
Lane 1: recombinant human CD142/F3/TF (Catalog No: HB058011), 50ng
Lane 2: recombinant human CD142/F3/TF (Catalog No: HB058011), 30ng
Lane 3: recombinant human CD142/F3/TF (Catalog No: HB058011), 20ng
Lane 4: recombinant human CD142/F3/TF (Catalog No: HB058011), 10ng

Flow-cytometry using APC anti-human CD142 antibody. A431 cells were stained with an irrelevant antibody (Blue Histogram) or an APC anti-human CD142 monoclonal antibody (Catalog HB058016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, and cells analysed on a NovoCyte Flow Cytometer.

Flow-cytometry using PE anti-human CD142 antibody. A431 cells were stained with an irrelevant antibody (Blue Histogram) or an PE anti-human CD142 monoclonal antibody (Catalog HB058016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, and cells analysed on a NovoCyte Flow Cytometer.

Flow-cytometry using FITC anti-human CD142 antibody. A431 cells were stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human CD142 monoclonal antibody (Catalog HB058016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, and cells analysed on a NovoCyte Flow Cytometer.
















+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206

中文
English
한국어
日本語
Español
Français
Русский